Boc-Thr-OHCAS# 2592-18-9 |
2D Structure
- Cisplatin
Catalog No.:BCN1552
CAS No.:14283-03-5
- Z-VAD-FMK
Catalog No.:BCC1126
CAS No.:187389-52-2
- Z-WEHD-FMK
Catalog No.:BCC1139
CAS No.:210345-00-9
- Z-LEHD-FMK
Catalog No.:BCC5117
CAS No.:210345-04-3
- AZ 10417808
Catalog No.:BCC2356
CAS No.:331645-84-2
- Apoptosis Activator 2
Catalog No.:BCC2099
CAS No.:79183-19-0
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 2592-18-9 | SDF | Download SDF |
PubChem ID | 6992539 | Appearance | Powder |
Formula | C9H17NO5 | M.Wt | 219.2 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (2S,3R)-3-hydroxy-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoate | ||
SMILES | CC(C(C(=O)[O-])NC(=O)OC(C)(C)C)O | ||
Standard InChIKey | LLHOYOCAAURYRL-RITPCOANSA-M | ||
Standard InChI | InChI=1S/C9H17NO5/c1-5(11)6(7(12)13)10-8(14)15-9(2,3)4/h5-6,11H,1-4H3,(H,10,14)(H,12,13)/p-1/t5-,6+/m1/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Boc-Thr-OH Dilution Calculator
Boc-Thr-OH Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.562 mL | 22.8102 mL | 45.6204 mL | 91.2409 mL | 114.0511 mL |
5 mM | 0.9124 mL | 4.562 mL | 9.1241 mL | 18.2482 mL | 22.8102 mL |
10 mM | 0.4562 mL | 2.281 mL | 4.562 mL | 9.1241 mL | 11.4051 mL |
50 mM | 0.0912 mL | 0.4562 mL | 0.9124 mL | 1.8248 mL | 2.281 mL |
100 mM | 0.0456 mL | 0.2281 mL | 0.4562 mL | 0.9124 mL | 1.1405 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Boc-Thr-OH
- 3'-Hydroxydehydroaglaiastatin
Catalog No.:BCN7725
CAS No.:259143-58-3
- D-Luciferin
Catalog No.:BCC6535
CAS No.:2591-17-5
- Yunaconitoline
Catalog No.:BCN6703
CAS No.:259099-25-7
- Hoechst 33258 analog
Catalog No.:BCC1624
CAS No.:258843-62-8
- Liensinine
Catalog No.:BCN6337
CAS No.:2586-96-1
- H-D-Cys(Trt)-OH
Catalog No.:BCC2914
CAS No.:25840-82-8
- Ghrelin (rat)
Catalog No.:BCC5767
CAS No.:258338-12-4
- IEM 1925 dihydrobromide
Catalog No.:BCC7885
CAS No.:258282-23-4
- Ghrelin (human)
Catalog No.:BCC7076
CAS No.:258279-04-8
- LEP (116-130) (mouse)
Catalog No.:BCC1016
CAS No.:258276-95-8
- Gemfibrozil
Catalog No.:BCC4783
CAS No.:25812-30-0
- Pelitinib (EKB-569)
Catalog No.:BCC1118
CAS No.:257933-82-7
- Boc-Lys(Boc)-ONp
Catalog No.:BCC3414
CAS No.:2592-19-0
- HOBt (anhydrous)
Catalog No.:BCC2816
CAS No.:2592-95-2
- EDC.HCl
Catalog No.:BCC2812
CAS No.:25952-53-8
- Allura Red AC
Catalog No.:BCN2220
CAS No.:25956-17-6
- 5-Acetyl-3-chloro-10,11-dihydro-5H-dibenz[b,f]azepine
Catalog No.:BCC8726
CAS No.:25961-11-9
- 5-Hydroxy-7-methoxy-3-(4-hydroxybenzylidene)chroman-4-one
Catalog No.:BCN1472
CAS No.:259653-54-8
- 2-Deacetyltaxuspine X
Catalog No.:BCN7375
CAS No.:259678-73-4
- T 705
Catalog No.:BCC4130
CAS No.:259793-96-9
- Hyponine D
Catalog No.:BCC8998
CAS No.:259823-31-9
- 4-Hydroxythiobenzamide
Catalog No.:BCC8709
CAS No.:25984-63-8
- Nimbolide
Catalog No.:BCN8053
CAS No.:25990-37-8
- Xylose
Catalog No.:BCC4880
CAS No.:25990-60-7
Efficient solution phase synthesis and use of multiple O-phosphothreonyl-containing peptides for calcium phosphate binding studies.[Pubmed:8463050]
Int J Pept Protein Res. 1993 Mar;41(3):275-81.
The protected phosphothreonine derivative Boc-Thr(PO3Ph2)-OH was prepared in high yield from Boc-Thr-OH by a simple three-step procedure which involved 4-nitrobenzylcarboxyl protection, either phosphorotriester (diphenyl phosphorochloridate) or "phosphite-triester" (diphenyl N,N-diethylphosphoramidite) phosphorylation of the threonine hydroxyl group of Boc-Thr-ONb followed by hydrogenolytic carboxyl deprotection. The three Thr(P)-containing peptides, H-Thr(P)-Glu-Glu-NHMe.TFA, H-Thr(P)-Thr(P)-Glu-Glu-NHMe.TFA and H-Thr(P)-Thr(P)-Thr(P)-Glu-Glu-NHMe.TFA, were prepared in high yield by the use of Boc-Thr(PO3Ph2)-OH in the Boc mode of peptide synthesis (mixed anhydride method) followed by platinum-mediated hydrogenolytic deprotection of the Thr(PO3Ph2)-containing peptides. The use of the phosphopeptides in calcium phosphate binding studies showed that the triple Thr(P)-cluster was a basic structural requirement, since only the pentapeptide was able to bind calcium phosphate efficiently.